Literature DB >> 11152484

Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein.

E C Coronel1, T Takimoto, K G Murti, N Varich, A Portner.   

Abstract

The paramyxovirus nucleoproteins (NPs) encapsidate the genomic RNA into nucleocapsids, which are then incorporated into virus particles. We determined the protein-protein interaction between NP molecules and the molecular mechanism required for incorporating nucleocapsids into virions in two closely related viruses, human parainfluenza virus type 1 (hPIV1) and Sendai virus (SV). Expression of NP from cDNA resulted in in vivo nucleocapsid formation. Electron micrographs showed no significant difference in the morphological appearance of viral nucleocapsids obtained from lysates of transfected cells expressing SV or hPIVI NP cDNA. Coexpression of NP cDNAs from both viruses resulted in the formation of nucleocapsid composed of a mixture of NP molecules; thus, the NPs of both viruses contained regions that allowed the formation of mixed nucleocapsid. Mixed nucleocapsids were also detected in cells infected with SV and transfected with hPIV1 NP cDNA. However, when NP of SV was donated by infected virus and hPIV1 NP was from transfected cDNA, nucleocapsids composed of NPs solely from SV or solely from hPIVI were also detected. Although almost equal amounts of NP of the two viruses were found in the cytoplasm of cells infected with SV and transfected with hPIV1 NP cDNA, 90% of the NPs in the nucleocapsids of the progeny SV virions were from SV. Thus, nucleocapsids containing heterologous hPIV1 NPs were excluded during the assembly of progeny SV virions. Coexpression of hPIV1 NP and hPIV1 matrix protein (M) in SV-infected cells increased the uptake of nucleocapsids containing hPIV1 NP; thus, M appears to be responsible for the specific incorporation of the nucleocapsid into virions. Using SV-hPIV1 chimera NP cDNAs, we found that the C-terminal domain of the NP protein (amino acids 420 to 466) is responsible for the interaction with M.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152484      PMCID: PMC114017          DOI: 10.1128/JVI.75.3.1117-1123.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  Domains of the measles virus N protein required for binding to P protein and self-assembly.

Authors:  B Bankamp; S M Horikami; P D Thompson; M Huber; M Billeter; S A Moyer
Journal:  Virology       Date:  1996-02-01       Impact factor: 3.616

4.  The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation.

Authors:  J Curran; H Homann; C Buchholz; S Rochat; W Neubert; D Kolakofsky
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly.

Authors:  C J Buchholz; D Spehner; R Drillien; W J Neubert; H E Homann
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA.

Authors:  P Calain; L Roux
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles.

Authors:  C J Buchholz; C Retzler; H E Homann; W J Neubert
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

8.  Sequence characterization and expression of the matrix protein gene of human parainfluenza virus type 1.

Authors:  U F Power; K W Ryan; A Portner
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

9.  Measles virus nucleocapsid protein expressed in insect cells assembles into nucleocapsid-like structures.

Authors:  A R Fooks; J R Stephenson; A Warnes; A B Dowsett; B K Rima; G W Wilkinson
Journal:  J Gen Virol       Date:  1993-07       Impact factor: 3.891

10.  Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion.

Authors:  T Bousse; T Takimoto; W L Gorman; T Takahashi; A Portner
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

View more
  40 in total

1.  A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Masayuki Shirakura; Tsuyoshi Tokusumi; Takahiro Hirata; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Critical role of Rab11a-mediated recycling endosomes in the assembly of type I parainfluenza viruses.

Authors:  Raychel Stone; Tsuyoshi Hayashi; Shringkhala Bajimaya; Erin Hodges; Toru Takimoto
Journal:  Virology       Date:  2015-10-17       Impact factor: 3.616

3.  Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles.

Authors:  Reed F Johnson; Sarah E McCarthy; Peter J Godlewski; Ronald N Harty
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus.

Authors:  Takeshi Noda; Shinji Watanabe; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  Interaction of Human Parainfluenza Virus Type 3 Nucleoprotein with Matrix Protein Mediates Internal Viral Protein Assembly.

Authors:  Guangyuan Zhang; Yi Zhong; Yali Qin; Mingzhou Chen
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

6.  Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.

Authors:  Gabriella Kiss; Jens M Holl; Grant M Williams; Eric Alonas; Daryll Vanover; Aaron W Lifland; Manasa Gudheti; Ricardo C Guerrero-Ferreira; Vinod Nair; Hong Yi; Barney S Graham; Philip J Santangelo; Elizabeth R Wright
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

7.  A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles.

Authors:  Olena Shtanko; Masaki Imai; Hideo Goto; Igor S Lukashevich; Gabriele Neumann; Tokiko Watanabe; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

8.  Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity.

Authors:  Geoffrey Chase; Daniel Mayer; Antonia Hildebrand; Ronald Frank; Yohei Hayashi; Keizo Tomonaga; Martin Schwemmle
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics.

Authors:  Mike C Wolf; Yao Wang; Alexander N Freiberg; Hector C Aguilar; Michael R Holbrook; Benhur Lee
Journal:  Virol J       Date:  2009-07-31       Impact factor: 4.099

10.  Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine.

Authors:  Satya Parida; Madhuchhanda Mahapatra; Sai Kumar; Subash C Das; Michael D Baron; John Anderson; Thomas Barrett
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.